Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Kidney International
|
November 13, 2002
Nephrotoxic nephritis is mediated by Fcgamma receptors on circulating leukocytes and not intrinsic renal cells
Ruth M Tarzi, Kevin A Davies, Michael G Robson, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 4, 2008
Fc gamma RIII and Fc gamma RIV are indispensable for acute glomerular inflammation induced by switch variant monoclonal antibodies
Angela Giorgini, Heather J Brown, Helen R Lock, et al.
The Journal of Pathology
|
May 29, 2016
Experimentally-induced anti-myeloperoxidase vasculitis does not require properdin, MASP-2 or bone marrow-derived C5
Simon J Freeley, Reena J Popat, Kiran Parmar, et al.
Trials
|
November 1, 2024
Paclitaxel- or sirolimus-coated balloons used for ArterioVEnous fistulas-2 (PAVE-2): study protocol for a randomised controlled trial to determine the efficacy of paclitaxel- or sirolimus-coated balloons in arteriovenous fistulas used for haemodialysis
Narayan Karunanithy, Sam Norton, Francis Calder, et al.
Cell Death & Disease
|
June 16, 2017
The NF-κB1 is a key regulator of acute but not chronic renal injury
Amy Fearn, Gerhard R Situmorang, Christopher Fox, et al.
Immunology
|
September 27, 2003
Decay-accelerating factor induction by tumour necrosis factor-alpha, through a phosphatidylinositol-3 kinase and protein kinase C-dependent pathway, protects murine vascular endothelial cells against complement deposition
Saifur R Ahmad, Elaine A Lidington, Rieko Ohta, et al.
JCI Insight
|
February 1, 2017
Anti-myeloperoxidase antibodies attenuate the monocyte response to LPS and shape macrophage development
Reena J Popat, Seran Hakki, Alpesh Thakker, et al.
Kidney International
|
August 31, 2016
Loss of endogenous thymosin β<sub>4</sub> accelerates glomerular disease
Elisavet Vasilopoulou, Maria Kolatsi-Joannou, Maja T Lindenmeyer, et al.
Trials
|
May 14, 2016
Paclitaxel-coated balloon fistuloplasty versus plain balloon fistuloplasty only to preserve the patency of arteriovenous fistulae used for haemodialysis (PAVE): study protocol for a randomised controlled trial
Narayan Karunanithy, Irene Rebollo Mesa, Anthony Dorling, et al.
The Journal of Experimental Medicine
|
February 4, 2021
Human marginal zone B cell development from early T2 progenitors
Thomas J Tull, Michael J Pitcher, William Guesdon, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Kidney International
|
November 13, 2002
Nephrotoxic nephritis is mediated by Fcgamma receptors on circulating leukocytes and not intrinsic renal cells
Ruth M Tarzi, Kevin A Davies, Michael G Robson, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 4, 2008
Fc gamma RIII and Fc gamma RIV are indispensable for acute glomerular inflammation induced by switch variant monoclonal antibodies
Angela Giorgini, Heather J Brown, Helen R Lock, et al.
The Journal of Pathology
|
May 29, 2016
Experimentally-induced anti-myeloperoxidase vasculitis does not require properdin, MASP-2 or bone marrow-derived C5
Simon J Freeley, Reena J Popat, Kiran Parmar, et al.
Trials
|
November 1, 2024
Paclitaxel- or sirolimus-coated balloons used for ArterioVEnous fistulas-2 (PAVE-2): study protocol for a randomised controlled trial to determine the efficacy of paclitaxel- or sirolimus-coated balloons in arteriovenous fistulas used for haemodialysis
Narayan Karunanithy, Sam Norton, Francis Calder, et al.
Cell Death & Disease
|
June 16, 2017
The NF-κB1 is a key regulator of acute but not chronic renal injury
Amy Fearn, Gerhard R Situmorang, Christopher Fox, et al.
Immunology
|
September 27, 2003
Decay-accelerating factor induction by tumour necrosis factor-alpha, through a phosphatidylinositol-3 kinase and protein kinase C-dependent pathway, protects murine vascular endothelial cells against complement deposition
Saifur R Ahmad, Elaine A Lidington, Rieko Ohta, et al.
JCI Insight
|
February 1, 2017
Anti-myeloperoxidase antibodies attenuate the monocyte response to LPS and shape macrophage development
Reena J Popat, Seran Hakki, Alpesh Thakker, et al.
Kidney International
|
August 31, 2016
Loss of endogenous thymosin β<sub>4</sub> accelerates glomerular disease
Elisavet Vasilopoulou, Maria Kolatsi-Joannou, Maja T Lindenmeyer, et al.
Trials
|
May 14, 2016
Paclitaxel-coated balloon fistuloplasty versus plain balloon fistuloplasty only to preserve the patency of arteriovenous fistulae used for haemodialysis (PAVE): study protocol for a randomised controlled trial
Narayan Karunanithy, Irene Rebollo Mesa, Anthony Dorling, et al.
The Journal of Experimental Medicine
|
February 4, 2021
Human marginal zone B cell development from early T2 progenitors
Thomas J Tull, Michael J Pitcher, William Guesdon, et al.
Page
of 5